Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Venetoclax Combined With Azacitidine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)UnknownNCT05513131
What this trial is testing

Clinical Study Protocol of Venetoclax Combined With Azacitidine and Harringtonine in the Treatment of sAML

Who this might be right for
Secondary Acute Myeloid Leukemia
The First Affiliated Hospital with Nanjing Medical University 30
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06470841
What this trial is testing

CHG Combined With Venetoclax and Azacytidine in Newly Diagnosed AML

Who this might be right for
Acute Myeloid Leukemia
Navy General Hospital, Beijing 85
Testing effectiveness (Phase 2)Looking for participantsNCT07743112
What this trial is testing

MAX-40279 Combined With Venetoclax and Azacitidine in Unfit Newly Diagnosed Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia
Maxinovel Pty., Ltd. 43
Testing effectiveness (Phase 2)UnknownNCT05949762
What this trial is testing

Safety and Efficacy of Venetoclax in Combination With Azacitidine and HA Regimen in the Treatment of AML in the Elderly

Who this might be right for
Acute Myeloid Leukemia
ZePing Zhou 45
Testing effectiveness (Phase 2)Looking for participantsNCT05736965
What this trial is testing

Selinexor in Combination With Azacitidine and Venetoclax (SAV Regimen) in Treatment Naïve Participants With Acute Myeloid Leukemia

Who this might be right for
AML, Adult
Shanghai Tong Ren Hospital 58
Large-scale testing (Phase 3)Looking for participantsNCT07514936
What this trial is testing

Venetoclax-Azacitidine in Combination With Chidamide and CAG in Fit Older Patients With Acute Myeloid Leukaemia

Who this might be right for
Newly Diagnosed Acute Myeloid Leukemia (AML)Elderly Patients
Chinese PLA General Hospital 120
Early research (Phase 1)Ended earlyNCT04336982
What this trial is testing

A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia

Who this might be right for
Leukemia, Myeloid, Acute
Celgene 22
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07813390
What this trial is testing

Homoharringtonine, Lisaftoclax, and Azacitidine for AML After Venetoclax-Based Therapy Failure

Who this might be right for
Acute Myeloid Leukemia (AML)
Guangdong Second Provincial General Hospital 73
Testing effectiveness (Phase 2)Looking for participantsNCT07304011
What this trial is testing

Olutasidenib With Azacitidine Followed by Olutasidenib Maintenance for the Treatment of IDH1-mutated Acute Myeloid Leukemia in Patients With Prior Treatment With Venetoclax Plus a Hypomethylating Agent

Who this might be right for
Acute Myeloid Leukemia
University of California, Davis 28
Early research (Phase 1)Study completedNCT04887857
What this trial is testing

Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Participants With Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia, Myeloid, Acute
Celgene 6
Testing effectiveness (Phase 2)Study completedNCT04266795
What this trial is testing

Pevonedistat and Venetoclax Combined With Azacitidine to Treat Acute Myeloid Leukemia (AML) in Adults Unable to Receive Intensive Chemotherapy

Who this might be right for
Acute Myeloid Leukemia (AML)
Takeda 164
Testing effectiveness (Phase 2)Looking for participantsNCT06611839
What this trial is testing

Venetoclax in Combination With Ivosidenib and Azacitidine for Newly Diagnosed IDH1-Mutated AML

Who this might be right for
AMLIDH1 MutationTreatment
Institute of Hematology & Blood Diseases Hospital, China 23
Early research (Phase 1)Looking for participantsNCT03874052
What this trial is testing

Ruxolitinib in Combination With Venetoclax With and Without Azacitidine in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia

Who this might be right for
Acute Myeloid Leukemia Arising From Previous Myelodysplastic SyndromeRecurrent Acute Myeloid LeukemiaRecurrent Secondary Acute Myeloid Leukemia+2 more
Jennifer Saultz 51
Early research (Phase 1)Looking for participantsNCT05735184
What this trial is testing

Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

Who this might be right for
Acute Myeloid LeukemiaMixed Lineage Leukemia Gene MutationRefractory AML+7 more
Kura Oncology, Inc. 420
Testing effectiveness (Phase 2)UnknownNCT05807347
What this trial is testing

Venetoclax Combined With Azacitidine and CAG in Refractory/Relapse Acute Myeloid Leukemia

Who this might be right for
Refractory/Relapse Acute Myeloid Leukemia
Hematology department of the 920th hospital 42
Testing effectiveness (Phase 2)Looking for participantsNCT05376111
What this trial is testing

Study of Venetoclax Combined With Azacitidine Regimen in Newly Diagnosed T-ALL Patients

Who this might be right for
T-cell Acute Lymphoblastic LeukemiaRecruiting
The First Affiliated Hospital of Soochow University 28
Not applicableNot Yet RecruitingNCT07635485
What this trial is testing

VA Induction and Bridging Transplantation for Hypoplastic/Secondary AML

Who this might be right for
Hypoplastic Acute Myeloid LeukemiaSecondary AML (Adult)
The First Affiliated Hospital of Soochow University 50
Large-scale testing (Phase 3)Active Not RecruitingNCT04401748
What this trial is testing

Study Of Venetoclax Tablet With Intravenous or Subcutaneous Azacitidine to Assess Change in Disease Activity In Adult Participants With Newly Diagnosed Higher-Risk Myelodysplastic Syndrome

Who this might be right for
Myelodysplastic Syndrome (MDS)
AbbVie 531
Large-scale testing (Phase 3)Looking for participantsNCT06810791
What this trial is testing

HVA vs IA/DA or VA in the Treatment of ND HR-AML

Who this might be right for
Newly Diagnosed Acute Myeloid Leukemia With High Risk
Nanfang Hospital, Southern Medical University 876
Testing effectiveness (Phase 2)Enrolling By InvitationNCT07517510
What this trial is testing

HVA in the Treatment of Mixed-Phenotype Acute Leukemia(MPAL).

Who this might be right for
Newly Diagnosed Mixed Phenotype Acute Leukemia (MPAL)
Guangdong Second Provincial General Hospital 40
Next Page